on July 26 the establishment of Denka Life Innovation Research Private Limited
(hereinafter "DLIR") in Biopolis, Singapore, with the aim of securing the Denka
Group''s first overseas R&D base specializing in the healthcare and life science
field.
Acting on its policy of aiding in cutting-edge R&D activities, the Singaporean
government established Biopolis, a complex designed to serve as a hub for
vibrant biomedical research. Since its opening, there has been a successful push
to recruit domestic and overseas research institutions and business corporations
to set up facilities in the complex, and, at present, Biopolis is home to a
large number of biomedical-related businesses'' research centers in addition to a
laboratory run by Singapore''s Agency for Science, Technology and Research
(A*STAR). The setting is conducive to government-private collaboration with a
focus on cutting-edge R&D. Denka itself has been engaged in ongoing joint
research into such materials as functional resins and elastomers with A*STAR in
the field of polymer science. When DLIR begins operations, Denka will launch a
new collaborative project in the life science field.
No comments:
Post a Comment